Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions. 

To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Company Growth (employees)
Type
Public
HQ
Jersey, GB
Founded
1986
Size (employees)
23,906 (est)
Website
shire.com
Shire was founded in 1986 and is headquartered in Jersey, GB

Key People at Shire

Graham Hetherington

Graham Hetherington

Chief Financial Officer
William Burns

William Burns

Non-Executive Director
Susan Kilsby

Susan Kilsby

Non-Executive Director
Steven Gillis

Steven Gillis

Non-Executive Director
David Kappler

David Kappler

Deputy Chairman

Shire Office Locations

Shire has offices in Jersey, Dublin, Lexington, Zug and in 38 other locations
Jersey, GB (HQ)
No. 99854, 22 Grenville Street, St Helier
Singapore, SG
3 Science Park Drive, #02-02/03 The Franklin, Singapore Science Park 1
Mexico City, MX
Av. Paseo de los Tamarindos 90, Torre 1, Piso 7, Col. Bosques de las Lomas, Del. Cuajimalpa
Tokyo, JP
Shinjuku Front Tower, 29th Floor, 2-21-1 Kita-Shinjuku, Shinjuku-ku
Berlin, DE
Friedrichstraße 149
Boulogne Billancourt, FR
88, rue du Dôme
São Paulo, BR
Av. das Nações Unidas, 14.171, 5o andar
Saint-Laurent, CA
2250 Alfred-Nobel Blvd, Suite 500
Zug, CH
Zählerweg 10
Lexington, US
300 Shire Way
Dublin, IE
5 Riverwalk

Shire Metrics

Shire Financial Metrics

Revenue (2016)

$11.4 b

Revenue growth (2015-16), %

78%

Gross profit

$7.6 b

Gross profit margin (2016), %

67%

Net income (2016)

$327.4 m

Market capitalization (21-Mar-2017)

$52.2 b

Closing share price (21-Mar-2017)

$176.2

Cash (31-Dec-2016)

$528.8 m
Shire's current market capitalization is $52.2 b.
Shire's revenue was reported to be $11.4 b in 2016 which is a 77.6% increase from the previous period.
FY, 2013Y, 2014Y, 2015Y, 2016

Revenue

£122.3 m$6 b$6.4 b$11.4 b

Revenue growth, %

(45%)7%78%

Cost of goods sold

$979.3 m$969 m$3.8 b

Gross profit

$5 b$5.4 b$7.6 b

Gross profit Margin, %

84%85%67%

R&D expense

$1.1 b$1.6 b$1.4 b

General and administrative expense

$1.8 b$1.8 b$3 b

Operating expense total

$4.3 b$5 b$10.4 b

EBIT

$1.7 b$1.4 b$962.9 m

EBIT margin, %

28%22%8%

Interest expense

$30.8 m$41.6 m$469.6 m

Interest income

$24.7 m$4.2 m$18.4 m

Pre tax profit

£626 k$3.3 b$1.4 b$486.1 m

Income tax expense

($56.1 m)($46.1 m)$126.1 m

Net Income

£1.6 m$3.4 b$1.3 b$327.4 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$528.8 m

Accounts Receivable

$2.6 b

Inventories

£455.3 m£544.8 m£635.4 m$3.6 b

Current Assets

£156.6 m£151.6 m£158.9 m$7.5 b

PP&E

£37 m£26.9 m£22.9 m

Goodwill

£225 k£166 k£107 k$17.9 b

Total Assets

£193.9 m£178.7 m£181.9 m$67 b

Accounts Payable

£1.8 m£424 k£486 k$4.3 b

Total Debt

£1.6 b

Current Liabilities

£23.6 m£13 m£12.1 m$7.7 b

Additional Paid-in Capital

£4.2 b£4.3 b£4.5 b$24.7 b

Retained Earnings

£1.6 m(£2.9 m)£2.9 m$5.9 b

Total Equity

£167 m£165.4 m£169.8 m$28.9 b

Debt to Equity Ratio

9.3 x

Debt to Assets Ratio

8.7 x

Financial Leverage

1.2 x1.1 x1.1 x2.3 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

£665.1 m£3.4 b£1.3 b$327.4 m

Depreciation and Amortization

£324.4 m£407.3 m£637.2 m$1.5 b

Accounts Receivable

(£210 m)($700 m)

Inventories

Accounts Payable

Cash From Operating Activities

$2.7 b

Purchases of PP&E

(£157 m)

Cash From Investing Activities

(£360.9 m)(£4 b)(£5.6 b)($18.1 b)

Cash From Financing Activities

$15.8 b

Interest Paid

(£29.9 m)(£14.5 m)(£20 m)($284 m)

Income Taxes Paid

£947 k£2.9 m(£2.6 m)

Shire Operating Metrics

Shire's Projects in R&D Pipeline was reported to be 37 in FY, 2016
FY, 2014FY, 2015FY, 2016

Projects in R&D Pipeline

272937

Ongoing Phase III Programs

71417

Shire Market Value History

Shire Revenue Breakdown

Shire's employees are reported to be approximately 52% female and 48% male.

Shire Median Salaries

Source: 25 public H-1B filings from Shire

Shire Online Presence

Shire News

Shire Company Life

You may also be interested in